Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results83% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 3 (2)
P 4 (2)

Trial Status

Completed5
Not Yet Recruiting2
Recruiting2
Unknown2
Withdrawn1
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (13)

Research Network

Activity Timeline